Biopharmaceutics & Drug Disposition
© John Wiley & Sons Ltd
Edited By: K. Sandy Pang
Impact Factor: 2.457
ISI Journal Citation Reports © Ranking: 2015: 116/253 (Pharmacology & Pharmacy)
Online ISSN: 1099-081X
Free Review articles
Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development
Jing Wang, Suhasini Iyer, et al.
Challenges and advances in the assessment of the disposition of antibody-drug conjugates
Amrita V. Kamath and Suhasini Iyer
Plasma vs heart tissue concentration in humans – literature data analysis of drugs distribution
Zofia Tylutki and Sebastian Polak
Dealing with the complex drug–drug interactions: Towards mechanistic models
Manthena V. Varma, K. Sandy Pang,et al.
Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin
Unji Lee and Euichaul Oh
Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy
Increased Impact Factor 2.457 !
Read, cite the journal, or submit your paper to keep contributing to the success of Biopharmaceutics & Drug Disposition.
Recently Published Articles
- You have full text access to this OnlineOpen articleIdentification of non-reported bupropion metabolites in human plasma (pages 550–560)
Jamie N. Connarn, Ruijuan Luo, Jim Windak, Xinyuan Zhang, Andrew Babiskin, Marisa Kelly, Gloria Harrington, Vicki L. Ellingrod, Masoud Kamali, Melvin McInnis and Duxin Sun
Version of Record online: 1 DEC 2016 | DOI: 10.1002/bdd.2046
- Selective Reduction in the Expression of UGTs and SULTs, a Novel Mechanism by which Piperine Enhances the Bioavailability of Curcumin in Rat
Xiaohui Zeng, Dake Cai, Qiaohuang Zeng, Zhao Chen, Guoping Zhong, Juncheng Zhuo, Haining Gan, Xuejun Huang, Ziming Zhao, Nan Yao, Dane Huang, Chengzhe Zhang, Dongmei Sun and Yuxing Chen
Accepted manuscript online: 23 NOV 2016 10:45PM EST | DOI: 10.1002/bdd.2049
- Evaluation of species difference in peripheral lymphocyte reduction effect of CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis (pages 561–573)
Shin-ichi Inaba, Maki Goto, Kaoru Tanaka-takanaka, Hisako Tanaka, Wataru Tomisato, Hiroshi Yuita, Hiromi Doi-Komuro, Ryotaku Inoue, Keiko Oshima, Takashi Kagari, Takaichi Shimozato and Takashi Izumi
Version of Record online: 14 NOV 2016 | DOI: 10.1002/bdd.2048
- Efavirenz does not meaningfully affect the single dose pharmacokinetics of 1200 mg raltegravir (pages 542–549)
Rajesh Krishna, Lilly East, Patrick Larson, Tara Siringhaus, Lisa Herpok, Crystal Bethel-Brown, Helen Manthos, John Brejda and Michael Gartner
Version of Record online: 14 NOV 2016 | DOI: 10.1002/bdd.2045